UMIN ID: UMIN000055692
Registered date:02/10/2024
Exploratory research of proteomics using human tear fluid samples
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Dry eye |
| Date of first enrollment | 2024/06/26 |
| Target sample size | |
| Countries of recruitment | Japan |
| Study type | Others,meta-analysis etc |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Protein expression profile data |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Subjects who were unable to collect tear fluid samples at either baseline or post treatment |
Related Information
| Primary Sponsor | Santen Pharmaceutical Co. Ltd. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Santen Pharmaceutical Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hiroyuki Shimizu |
| Address | 4-20, Ofukacho, Kita-ku, Osaka Japan 530-8552 |
| Telephone | 06-4802-9339 |
| translational.research@santen.com | |
| Affiliation | Santen Pharmaceutical Co. Ltd. Ophthalmology Innovation center |
| scientific contact | |
| Name | Tomoko Kirihara |
| Address | 4-20, Ofukacho, Kita-ku, Osaka Japan |
| Telephone | 06-4802-9339 |
| translational.research@santen.com | |
| Affiliation | Santen Pharmaceutical Co. Ltd. Ophthalmology Innovation center |